CalciMedica, Inc.
NASDAQ: CALC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- A. Rachel Leheny
- Employees
- 14
- Headquarters
- La Jolla, United States
- IPO year
- 2023
- Market cap
- $9.4M
- Website
- https://www.calcimedica.com
Loading CALC…
Loading profile data…Frequently asked questions about CALC
What does CalciMedica, Inc. (CALC) do?
CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the...
Where does CALC trade?
CalciMedica, Inc. (CALC) trades on the NASDAQ Capital Market.
What sector is CALC in?
CalciMedica, Inc. (CALC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of CalciMedica, Inc.?
A. Rachel Leheny is the chief executive officer of CalciMedica, Inc. (CALC).
Where is CalciMedica, Inc. headquartered?
CalciMedica, Inc. is headquartered in United States.
Does CALC pay a dividend?
CalciMedica, Inc. (CALC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CALC go public?
CalciMedica, Inc. (CALC) completed its initial public offering in 2023.